A randomized, double-blind, placebo-controlled crossover clinical trial of mineral absorption by lactulose intake in adults. - A clinical trial of mineral absorption by lactulose intake in adults.

KSO Corporation0 个研究点目标入组 100 人开始时间: 2023年11月17日最近更新: 2024年1月22日

试验速览

暂无简介。

•1)Subjects undergoing treatment for liver, kidney, heart, lung, gastrointestinal, hematological, endocrine, and infectious diseases, or those with a serious history of these diseases. 2)Subjects with a history of gastrointestinal resection (excluding appendicitis). 3)Subjects with gastrointestinal dysfunction such as irritable bowel syndrome or inflammatory bowel disease. 4)Subjects who regularly use medicine that affect the gut microbiota or bone metabolism (antibiotics, active biopharmaceuticals, laxatives, active vitamin D3, etc.) 5)Subjects who regularly use food with functional claims that improve the gut microbiota or maintain bone density or improve bone metabolism or promote mineral absorption, or foods containing vitamin D3 or mineral. 6)Subjects with serious allergies to medicines and food. 7)Subjects with lactose intolerance. 8)Subjects who participate in another clinical study within 3months before providing written consent to participate in the present study. 9)Subjects who are judged inappropriate for the study by principal investigator.

发起方